AB2 Bio operates as a drug discovery and development company that specializes in developing therapies for the treatment of severe systemic inflammatory diseases. The Company primarily focuses on developing drugs that treat the symptoms, as well as target the underlying causes of inflammation-based diseases. Its portfolio includes Interleukin-18 Binding Protein, a human protein with a high affinity for IL-18, a major inflammatory cytokine for inflammatory diseases treatment.
|Employees (est.) (Oct 2019)||23||(-4%)|
AB2 Bio latest funding size
Time since last funding
|4 years ago|
When was AB2 Bio founded?
AB2 Bio was founded in 2010.
Who are AB2 Bio key executives?
AB2 Bio's key executives are Andrew Sleight, Fernando Cunha and Eduardo Schiffrin.
How many employees does AB2 Bio have?
AB2 Bio has 23 employees.
Who are AB2 Bio competitors?
Competitors of AB2 Bio include Pandion Therapeutics, MedDay and NeuralStem.
Where is AB2 Bio headquarters?
AB2 Bio headquarters is located at EPFL Innovation Park Building B, Lausanne.
Where are AB2 Bio offices?
AB2 Bio has an office in Lausanne.
How many offices does AB2 Bio have?
AB2 Bio has 1 office.
Receive alerts for 300+ data fields across thousands of companies